These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2722488)

  • 1. Twice-a-day radiotherapy for T3 squamous cell carcinoma of the glottic larynx.
    Parsons JT; Mendenhall WM; Mancuso AA; Cassisi NJ; Stringer SP; Million RR
    Head Neck; 1989; 11(2):123-8. PubMed ID: 2722488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperfractionated radiotherapy in the treatment of squamous cell carcinomas of the supraglottic larynx.
    Wendt CD; Peters LJ; Ang KK; Morrison WH; Maor MH; Goepfert H; Oswald MJ
    Int J Radiat Oncol Biol Phys; 1989 Nov; 17(5):1057-62. PubMed ID: 2808039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage surgery after radiotherapy failure in T1-T2 squamous cell carcinoma of the glottic larynx.
    McLaughlin MP; Parsons JT; Fein DA; Stringer SP; Cassisi NJ; Mendenhall WM; Million RR
    Head Neck; 1996; 18(3):229-35. PubMed ID: 8860763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T2 glottic cancer. Recurrence, salvage, and survival after definitive radiotherapy.
    Howell-Burke D; Peters LJ; Goepfert H; Oswald MJ
    Arch Otolaryngol Head Neck Surg; 1990 Jul; 116(7):830-5. PubMed ID: 2363922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of radiotherapy and surgery as primary treatment in the management of T3 N0 M0 glottic tumours.
    Simpson D; Robertson AG; Lamont D
    J Laryngol Otol; 1993 Oct; 107(10):912-5. PubMed ID: 8263389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy of early-stage glottic cancer: analysis of factors affecting prognosis.
    Chen MF; Chang JT; Tsang NM; Liao CT; Chen WC
    Ann Otol Rhinol Laryngol; 2003 Oct; 112(10):904-11. PubMed ID: 14587984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can pretreatment computed tomography findings predict local control in T3 squamous cell carcinoma of the glottic larynx treated with radiotherapy alone?
    Lee WR; Mancuso AA; Saleh EM; Mendenhall WM; Parsons JT; Million RR
    Int J Radiat Oncol Biol Phys; 1993 Mar; 25(4):683-7. PubMed ID: 8454487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence after radiotherapy for glottic carcinoma.
    Viani L; Stell PM; Dalby JE
    Cancer; 1991 Feb; 67(3):577-84. PubMed ID: 1898708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control.
    Fein DA; Mendenhall WM; Parsons JT; Million RR
    Int J Radiat Oncol Biol Phys; 1993 Mar; 25(4):605-11. PubMed ID: 8454477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-adapted partial larynx and/or carotid artery sparing modulated radiation therapy of glottic cancer.
    Janssen S; Glanzmann C; Huber G; Studer G
    Radiat Oncol; 2014 Jun; 9():136. PubMed ID: 24923417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage T3 squamous cell carcinoma of the glottic larynx treated with surgery and/or radiation therapy.
    Mendenhall WM; Million RR; Sharkey DE; Cassisi NJ
    Int J Radiat Oncol Biol Phys; 1984 Mar; 10(3):357-63. PubMed ID: 6423584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radiotherapy in glottic T1 carcinoma. Local control and survival].
    Herranz J; Fernández M; Ramos S; Vázquez Barro C; Sarandeses García A; Martínez Vidal J; Veiras C
    Acta Otorrinolaringol Esp; 2000; 51(1):57-61. PubMed ID: 10799934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation therapy for stage I and II laryngeal cancer using 10 MV X-rays or cobalt-60 gamma-rays.
    Hayakawa K; Mitsuhashi N; Tamaki Y; Takahashi M; Honjo J; Kamei T; Koyama I; Niibe H
    Radiat Med; 1992; 10(5):199-205. PubMed ID: 1438927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of EpCAM and prognosis in early-stage glottic cancer treated by radiotherapy.
    Murakami N; Mori T; Yoshimoto S; Ito Y; Kobayashi K; Ken H; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Sumi M; Itami J
    Laryngoscope; 2014 Nov; 124(11):E431-6. PubMed ID: 25043563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors of local control after radiotherapy in T1 glottic and supraglottic carcinoma of the larynx.
    Carl J; Andersen LJ; Pedersen M; Greisen O
    Radiother Oncol; 1996 Jun; 39(3):229-33. PubMed ID: 8783399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy.
    Chera BS; Amdur RJ; Morris CG; Kirwan JM; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):461-6. PubMed ID: 20153124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curative radiotherapy for stage II-III squamous cell carcinoma of the glottic larynx.
    Medini E; Medini I; Lee CK; Gapany M; Levitt SH
    Am J Clin Oncol; 1998 Jun; 21(3):302-5. PubMed ID: 9626804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exclusive radiotherapy for stage T1-T2N0M0 lanryngeal cancer: retrospective study of 59 patients at CFB and CHU de Caen.
    Cuny F; Géry B; Florescu C; Clarisse B; Blanchard D; Rame JP; Babin E; De Raucourt D
    Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Nov; 130(5):251-6. PubMed ID: 23759281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation therapy of glottic carcinoma: Peter MacCallum Cancer Institute experience.
    Guiney M; Smith J; Hughes P; Narayan K
    Aust N Z J Surg; 1992 Aug; 62(8):622-7. PubMed ID: 1642583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definitive radiotherapy for early (T1-T2) glottic squamous cell carcinoma: a 20 year Cleveland Clinic experience.
    Khan MK; Koyfman SA; Hunter GK; Reddy CA; Saxton JP
    Radiat Oncol; 2012 Nov; 7():193. PubMed ID: 23164282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.